KEAP1 and cancer: Therapy‐resistant cancer cells are sensitive to treatments targeting the lipid peroxidase pathway.[34] Inhibition of the p62‐Keap1‐NRF2 pathway reverses sorafenib resistance in HCC cells.[71] Hence, exploring the role of ferroptosis in chemotherapy resistance in CRC is imperative.